Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

5.36
-0.0700-1.29%
Post-market: 5.360.00000.00%19:30 EDT
Volume:276.67K
Turnover:1.50M
Market Cap:320.96M
PE:-5.36
High:5.53
Open:5.45
Low:5.27
Close:5.43
52wk High:5.78
52wk Low:2.20
Shares:59.88M
Float Shares:33.00M
Volume Ratio:0.45
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9995
EPS(LYR):-1.1091
ROE:-397.30%
ROA:-45.73%
PB:16.61
PE(LYR):-4.83

Loading ...

Aug 10, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2026

Major Issues Report

Form 8-K - Current report
Jun 23, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Feb 06, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 06, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 28, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jul 31, 2025

Major Issues Report

Form 8-K - Current report
Jun 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities